Assessment System of Sarcopenia in Lung Cancer Patients
Trial Parameters
Brief Summary
1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer. 2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period. 3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer.
Eligibility Criteria
Inclusion Criteria: 1. Hospitalized patients scheduled for radical resection of lung cancer. 2. With a CT/MRI examination within 1 week. 3. The compliance of examination was good. Exclusion Criteria: 1. Amputated arm or leg. 2. Severe oedema (oedema higher than knee level). 3. Implantable pacemaker. 4. Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study.